Phospho-control of TGF-beta superfamily signaling

Katharine H Wrighton1, Xia Lin, Xin-Hua Feng

  • 1Michael E. DeBakey Department of Surgery, Department of Molecular & Cellular Biology and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

Cell Research
|December 31, 2008
PubMed

Insights

Transforming growth factor-beta (TGF-beta) signaling, crucial for cellular responses, relies on R-Smad phosphorylation. Reversible phosphorylation controls TGF-beta pathway strength and duration, impacting disease pathogenesis.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) family proteins regulate diverse cellular functions through autocrine, paracrine, and endocrine signaling.
  • Aberrant TGF-beta signaling is implicated in the pathogenesis of various diseases, notably cancer.
  • TGF-beta signaling is initiated by a phospho-cascade, leading to receptor and downstream R-Smad phosphorylation.

Purpose of the Study:

  • To illustrate the critical roles of reversible phosphorylation in regulating TGF-beta signaling.
  • To highlight the dynamic nature of Smad (de)phosphorylation in controlling signaling strength and duration.

Main Methods:

  • The study focuses on the molecular mechanisms of TGF-beta signaling.
  • It reviews the process of R-Smad phosphorylation and dephosphorylation.
  • Emphasis is placed on the regulatory role of phosphatases in TGF-beta pathways.

Main Results:

  • R-Smad phosphorylation state dictates Smad complex formation, nuclear translocation, transcriptional activity, and protein stability.
  • Dephosphorylation of R-Smads by phosphatases serves to terminate or prevent TGF-beta signaling.
  • Reversible phosphorylation is a tightly controlled event essential for modulating TGF-beta pathway dynamics.

Conclusions:

  • Reversible phosphorylation of R-Smads is a pivotal regulatory mechanism in TGF-beta signaling.
  • Understanding Smad (de)phosphorylation is key to comprehending the control over TGF-beta signaling strength and duration.
  • This regulatory control is fundamental for physiological responses and preventing disease states linked to aberrant signaling.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...